Nathaniel S. Gardiner - Net Worth and Insider Trading
Nathaniel S. Gardiner Net Worth
The estimated net worth of Nathaniel S. Gardiner is at least $2 Million dollars as of 2024-05-06. Nathaniel S. Gardiner is the Sr. VP & General Counsel of Enanta Pharmaceuticals Inc and owns about 104,080 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $2 Million. Details can be seen in Nathaniel S. Gardiner's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nathaniel S. Gardiner has not made any transactions after 2023-12-05 and currently still holds the listed stock(s).
Transaction Summary of Nathaniel S. Gardiner
Nathaniel S. Gardiner Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nathaniel S. Gardiner owns 1 companies in total, including Enanta Pharmaceuticals Inc (ENTA) .
Click here to see the complete history of Nathaniel S. Gardiner’s form 4 insider trades.
Insider Ownership Summary of Nathaniel S. Gardiner
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2023-12-05 | director |
Nathaniel S. Gardiner Latest Holdings Summary
Nathaniel S. Gardiner currently owns a total of 1 stock. Nathaniel S. Gardiner owns 104,080 shares of Enanta Pharmaceuticals Inc (ENTA) as of December 5, 2023, with a value of $2 Million.
Latest Holdings of Nathaniel S. Gardiner
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2023-12-05 | 104,080 | 15.17 | 1,578,894 |
Holding Weightings of Nathaniel S. Gardiner
Nathaniel S. Gardiner Form 4 Trading Tracker
According to the SEC Form 4 filings, Nathaniel S. Gardiner has made a total of 1 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 2,412 shares on December 5, 2023, which brought Nathaniel S. Gardiner around $23,228.
Insider Trading History of Nathaniel S. Gardiner
- 1
Nathaniel S. Gardiner Trading Performance
GuruFocus tracks the stock performance after each of Nathaniel S. Gardiner's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nathaniel S. Gardiner is -2.82%. GuruFocus also compares Nathaniel S. Gardiner's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nathaniel S. Gardiner within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nathaniel S. Gardiner's insider trading performs compared to the benchmark.
Performance of Nathaniel S. Gardiner
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.11 | | | | | |
| Relative Return to S&P 500(%) | -4.64 | | | | | |
Nathaniel S. Gardiner Ownership Network
Nathaniel S. Gardiner Owned Company Details
What does Enanta Pharmaceuticals Inc do?
Who are the key executives at Enanta Pharmaceuticals Inc?
Nathaniel S. Gardiner is the director of Enanta Pharmaceuticals Inc. Other key executives at Enanta Pharmaceuticals Inc include Chief Medical Officer Scott T. Rottinghaus , Sr. VP & Business Dev. Brendan Luu , and Sr. VP & New Product Dev. Tara Lynn Kieffer .
Enanta Pharmaceuticals Inc (ENTA) Insider Trades Summary
Over the past 18 months, Nathaniel S. Gardiner made 1 insider transaction in Enanta Pharmaceuticals Inc (ENTA) with a net sale of 2,412. Other recent insider transactions involving Enanta Pharmaceuticals Inc (ENTA) include a net sale of 65,142 shares made by Jay R. Luly , a net sale of 16,337 shares made by Yat Sun Or , and a net sale of 12,852 shares made by Paul J Mellett .
In summary, during the past 3 months, insiders sold 0 shares of Enanta Pharmaceuticals Inc (ENTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,822 shares of Enanta Pharmaceuticals Inc (ENTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,822 shares.
Enanta Pharmaceuticals Inc (ENTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enanta Pharmaceuticals Inc Insider Transactions
Nathaniel S. Gardiner Mailing Address
Above is the net worth, insider trading, and ownership report for Nathaniel S. Gardiner. You might contact Nathaniel S. Gardiner via mailing address: C/o Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
